PACS Group, Inc. PACS
NYSE PACS
$42.89 +1.87 (+4.56%)
At close: Oct 2, 2026 · 4:00 PM EDT

Pacs (PACS) Gains from Sales and Divestitures (2023 - 2024)

Updated

Pacs (PACS) reported Gains from Sales and Divestitures of -$343,000 for Q1 2024, compared with -$4,000 a year earlier.

Analysis

Pacs (PACS) Gains from Sales and Divestitures (2023 - 2024) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 HCA Healthcare 93.08 Bn 92.52 Bn -
2 Natera 58.93 Bn 54.61 Bn 485.19 Mn
3 Quest Diagnostics 25.75 Bn 24.18 Bn 1.03 Bn
4 Labcorp Holdings 24.96 Bn 22.73 Bn 1.11 Bn
5 Guardant Health 23.76 Bn 19.82 Bn 219.03 Mn
6 Tenet Healthcare 20.83 Bn 11.98 Bn -
7 Tempus AI 13.43 Bn 10.46 Bn 246.50 Mn
8 BrightSpring Health Services 11.90 Bn 10.24 Bn 492.75 Mn
9 Encompass Health 11.82 Bn 12.29 Bn -
10 Pacs 6.79 Bn 5.83 Bn 338.46 Mn
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2024 -343,000.00
Jun 30, 2023 -512,000.00
Mar 31, 2023 -4,000.00
API Access

Pacs Gains from Sales and Divestitures API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=gains-from-sales-and-divestitures&ticker=PACS&period=max&api_key=YOUR_API_KEY